Chemotherapy-induced oral mucositis management: A retrospective analysis of MuGard, Caphosol, and standard supportive care measures.

Joshua L MurdockDavid J Reeves

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2019)

MuGard and Caphosol did not demonstrate any benefits compared to standard topical therapy at reducing pain scores or increasing mucosal recovery in the treatment of oral mucositis.

Keyphrases

chemotherapy induced
pain management
chronic pain
healthcare
radiation induced
palliative care
neuropathic pain
combination therapy
spinal cord
mesenchymal stem cells
radiation therapy
ulcerative colitis
affordable care act
bone marrow
health insurance